Annex 2. The list of MODEL BIOCLUSTERS including those not chosen The tables below provide the information on the pool of all preselected bioclusters existing in Europe, USA, Canada, and Asia. Clusters in Europe Upper Austrian Food Cluster AUSTRIA (Lebensmittel-cluster, Linz, Province of Upper Austria) 1. General Information o Cluster development stage o - Early development/Growing o - Established in 2000 as the Upper Austrian Food Cluster (LC OÖ). o - Evolution of the LC OÖ network has been extremely dynamic since the formation of the cluster. 2. Scientific Base o -N.d. 3. Industrial Base o - N.d. 4. Financial Base o Government Funds: names of o - Measures within the framework of the Upper Austrian Food Cluster are funds, investment conditions, financed by the Province of Upper Austria, the Upper Austrian Chamber of volume of capital Commerce and contributions from network partners. 5. Support Base o - N.d. 6. Cooperation and aggregation o Cooperation other clusters in o - Use of synergy to enhance innovatory strength improves regional and supra- different regions and/or countries regional competitiveness. - Increasing competitiveness and innovatory strength through co-operation is highly emphasized. o Cooperation or aggregation via o - Close co-operation within the LC OÖ network between the farming industry other means and commerce. Over 1.000 farmers are involved in LC OÖ projects. 7. Additional information o – N.d. 8. Sources o http://www.lebensmittelcluster.at/startseite/lebensmittel_cluster/english_descri ption.html Agrobiopole Wallon BELGIUM (Gembloux,Waloonia Region) 1. General Information o Cluster development stage o -Amount of staff: 22 o Cluster objectives o - Main objectives are to federate experts in diverse sectors in bioraffinage, reinforce its activities and to position its experts on a European scene. o - Assists organizations that develop their activities in terms of bioraffinage. o - Pole of excellence in the fields of agronomy and biotechnologies in general, 1 Agrobiopole Wallon BELGIUM (Gembloux,Waloonia Region) with the mission to serve the development of the region Walloonia o Number of publicly traded o - Affiliated companies include Pharma manufacturing, Wetlands engineering, companies Agrostar and Immolabo. - Scientific institutions, private organizations, associations and public institutions. 2. Scientific Base o – N.d. 3. Industrial Base o – N.d. 4. Financial Base o Government Funds: names of funds, o - Dependant from governmental sponsors such as the Walloon Region, State of investment conditions, volume of Belgium or the European Union- capital 5. Support Base o – N.d. 6. Cooperation and aggregation o – N.d. 7. Additional information o – N.d. 8. Sources o http://www.agrobiopole.be/pdf/Plaquette%20FRsept09.pdf Ghent Bio-Energy Valley BELGIUM (Ghent, Flanders Region) 1. General Information o Cluster development stage o -Early development/ growing o -Founded in 2005. o - Leading initiative in development biobased economy. o Cluster objectives o - Promotes the development of the biobased economy through collaborative programs, joint initiatives and synergy creation between the partners in the fields of R&D, structural measures and policy, logistics and communication towards the general public o - Ultimate aim of Ghent Bio-energy valley is to promote the development of the so-called knowledge-based bio-economy o Number of publicly traded o - Major industrial partners include Electrabel – GDF-Suez, Cargill and companies Capricorn o - Electrabel is the key energy player in Belgium. 2. Scientific Base o Number of universities: names of o - University of Ghent main player in biotechnology. The university is the major ones, research focus and largest one in the Dutch speaking area with approximately 60,000 students and number of students 2600 international students. o -Flemish institute of biotechnology (Incorporated in the University of Ghent), one of the world’s leading institutes in biotechnology. o - Great biotechnologic expertise in Flanders. o Number of research institutes: o - About 11 Research groups. names of major ones, research focus areas and number of employees 2 Ghent Bio-Energy Valley BELGIUM (Ghent, Flanders Region) 3. Industrial Base o - N.d. 4. Financial Base o - N.d. o Government Funds: names of funds, o - Recently, the EU gave a € 6 million subsidy for Bio Base Europe investment conditions, volume of capital 5. Support Base o Legal regime: specialized legal o - Belgium is one of the last countries in the EU where a legal framework in structures incl. tax cuts regards to adding bio fuel is still absent. The issue is currently being addressed. 6. Cooperation and aggregation o Cooperation other clusters in o - December 2008: Europe, Flanders and The Netherlands have joined forces different regions and/or countries within the framework of an Interreg IV project and allocated € 21 million to Bio Base Europe. o - Bio Base Europe is the result of a partnership between Ghent Bio-Energy Valley and Biopark Terneuzen and their respective stakeholders. o -Largest Interregion project ever granted to the Dutch-Flemish border-region o Cooperation or aggregation via other o - Joint initiative of Ghent University, the Port of Ghent, the Development means Agency of East-Flanders and a number of industrial companies in the Greater Ghent area. 7. Additional information o – N.d. 8. Sources o http://www.gbev.org/web/en.php o http://www.gbev.org/pdf/GBEV%20workshop%2018%20mei%2009.pdf o http://www.vilt.be/Wout_Boerjan__VIB/Gent_blijft_wereldtop_in_groene_bio technologie Aarhus Cluster DENMARK 1. General Information o Cluster development stage o - Early development: Cluster of Aarhus is still in its embryonic phase. o Number of publicly traded o - Cluster currently encompasses 22 DBFs, of which the large majority has less companies than 5 employees. - 9 out of 22 DBFs operate in drug discovery processes, 4 in specializing diagnostic tools and the others mainly provide support services. o Estimated ratio biomedical versus o - Large majority of biotech companies in the cluster were founded between non-biomedical companies: XY 1998 and 2001 in correspondence with the global economic growth period 2. Scientific Base o Number of universities: names of o - Aarhus region is a major education and research center, providing a major ones, research focus and favourable background for the cluster birth. number of students 3. Industrial Base o Number of large enterprises in o - Includes promising high growth companies, 75% of which are located in the 3 Aarhus Cluster DENMARK biotech: names of major ones, science park product focus areas, number of employees o Existing success stories in biotech: o - 33% of the recently founded DBFs are already profitable but overall turnover well-known products/ business remains low cases/ companies 4. Financial Base o Government Funds: names of funds, o - Danish government has invested massively in the biotech industry. investment conditions, volume of capital 5. Support Base o Cluster promotion agencies (incl. o Availability of science parks (i.e. Aarhus Science Park and the Biomedical Science parks, incubators): name, Science Park) function 6. Cooperation and aggregation o - N.d. 7. Additional information o - N.d. 8. Sources o http://books.google.lu/books?id=T_MYEg9phXEC&pg=PA92&lpg=PA92&d q=aarhus+cluster&source=bl&ots=malKS7WInB&sig=4zItCv95AwggfXRsjq AHCVqDLWI&hl=de&ei=P2HlSqTIKs2K4QaR8NmLDQ&sa=X&oi=book_r esult&ct=result&resnum=1&ved=0CAcQ6AEwAA#v=onepage&q=aarhus%2 0cluster&f=false Medicon Valley DENMARK –SWEDEN (Greater Copenhagen and Skåne Region) 1. General Information o Cluster development stage o – Mature o - One of Europe's strongest life science clusters o Cluster typology o - Hybrid o - Unique interplay between hospitals, universities, public research institutions, industry and investors. o Number of publicly traded o - Cluster with over 100 biotech companies, more than 200 medtech companies companies and more than 50 relevant service providers. 2. Scientific Base o Number of universities: names of o - Comprises a dense cluster of universities, hospitals and companies within life major ones, research focus and science, many of which are R&D based. number of students 3. Industrial Base o Number of large enterprises in o - Companies such as Novo Nordisk, H. Lundbeck, AstraZeneca and LEO biotech: names of major ones, Pharma, have significantly contributed to the development of the region by product focus areas, number of strengthening abilities within applied research, attracting suppliers and 4 Medicon Valley DENMARK –SWEDEN (Greater Copenhagen and Skåne Region) employees producing spin-offs 4. Financial Base o Government Funds: names of funds, o - Medicon valley relies on both private and public R&D spending and both the investment conditions, volume of Danish and Swedish governments are dedicated to increasing R&D spending capital over the coming years 5. Support Base o - N.d. 6. Cooperation and aggregation o Cooperation other clusters in o - Interregion project. different regions and/or countries o - Public authorities and life science industry in Copenhagen and Southern Sweden agreed to market the region internationally and aim to become the most attractive bioregion in Europe. 7. Additional information o - N.d. 8. Sources o http://www.mediconvalley.com/ o www.mva.org Agropolis International (Montpelier) FRANCE 1. General Information o Cluster development stage o - Maturing: Founded in 1986. o Number of publicly traded o - 1 consultation group, 25 associated members